<img alt="" src="https://secure.hero6bell.com/211997.png" style="display:none;">

Investor relations

Why invest in Bio-Works?

We develop products and solutions that make important biotechnology medicines available and accessible to everyone. As such, an investment in Bio-Works  allows participation in the biopharmaceutical industry with a lower risk profile than direct investments in biotech scale-ups. 

Interim report 2021

The interim report for 1H21 is now available.

Download the report (in Swedish)

Latest press release (in Swedish)

Financial calendar

2021-11-25 Extra general meeting
2022-02-18 End of year report
2021-05-20 Annual general meeting

Contact - Investor relations

Investor relations

Jonathan Royce

Chief Executive Officier, Bio-Works Technologies

Certified adviser

FNCA Sweden AB

Certified adviser, Bio-Works Technologies
Website: www.fnca.se

First North Disclaimer

First North is an alternative marketplace operated by an exchange within the NASDAQ OMX group. Companies on First North are not subject to the same rules as companies on the regulated main market. Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a company on First North may therefore be higher than investing in a company on the main market. All companies with shares traded on First North have a Certified Adviser who monitors that the rules are followed. The Exchange approves the application for admission to trading.